bodnarchuk/iStock via Getty Images Paulson & Co. exited its position in AngloGold Ashanti ( NYSE: AU ) in Q3, according to the fund's latest 13F filing. The fund increased its stake in Madrigal Pharmaceuticals.
Paulson & Co. also reduced its position in Altice USA ( ATUS ) in.
